PRIMARY PERITONEAL
Clinical trials for PRIMARY PERITONEAL explained in plain language.
Never miss a new study
Get alerted when new PRIMARY PERITONEAL trials appear
Sign up with your email to follow new studies for PRIMARY PERITONEAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for hard-to-treat ovarian cancer: targeted drug enters phase 2 trial
Disease control Recruiting nowThis study tests a drug called TORL-1-23 in 230 women with advanced ovarian, fallopian tube, or peritoneal cancer that no longer responds to platinum chemotherapy and has a specific marker (claudin 6). The goal is to see if the drug can shrink tumors and how safe it is. Participa…
Matched conditions: PRIMARY PERITONEAL
Phase: PHASE2 • Sponsor: TORL Biotherapeutics, LLC • Aim: Disease control
Last updated May 11, 2026 20:38 UTC
-
New drug dosing study aims to improve ovarian cancer treatment
Disease control Recruiting nowThis study tests a drug called mirvetuximab soravtansine (MIRV) in people with a type of ovarian cancer that no longer responds to platinum chemotherapy. The drug targets a protein (FRα) on cancer cells to deliver a cell-killing agent. About 110 participants will receive MIRV on …
Matched conditions: PRIMARY PERITONEAL
Phase: PHASE2 • Sponsor: AbbVie • Aim: Disease control
Last updated May 07, 2026 18:39 UTC
-
Drug interaction study aims to improve ovarian cancer treatment
Knowledge-focused Recruiting nowThis study looks at how the antifungal drug itraconazole changes the levels of a cancer drug in the blood of people with ovarian, primary peritoneal, or fallopian tube cancer. About 24 participants will take both drugs in a fixed order to measure drug levels over time. The goal i…
Matched conditions: PRIMARY PERITONEAL
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated May 17, 2026 04:16 UTC